Featured Posts
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
City Journal
Ignoring the Science
A new CDC study reports that the first updated Covid-19 vaccine—the bivalent vaccine approved in fall 2022—was about 50 percent effective in blocking infection over a two-month…
The Federalist Society
Explainer 62 – FDA’s Regulation of Laboratory Developed Tests
CEI’s Joel Zinberg joined a podcast hosted by The Federalist Society for the Regulatory Transparency Project on the FDA’s regulation of laboratory developed tests:…
Search Posts
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
News Release
CEI Welcomes Senior Fellow with Health Care and Legal Expertise
The Competitive Enterprise Institute is pleased to welcome medical and legal expert Joel M. Zinberg, M.D., J.D. as a senior fellow working on health care…
Blog
How SEC Accounting Regulations Hindered National Stockpile—and Still May Be Doing So
In a new report, CEI experts outline #NeverNeeded regulations that are frustrating responses to the pandemic and its aftermath. Among those is an obscure Securities…
Blog
Getting Rid of #NeverNeeded Regulations Hindering Coronavirus Response
What can Washington do to minimize harm from the coronavirus? Some of the best policy responses are coming not from imposing new regulations, but from…
Blog
Liberty in the Time of Coronavirus Part 2
Much of the money dedicated to medical research and services comes from the federal government. While some may see this is a good way to…
Blog
Regulation, Confusion, and the Irony of Emergency COVID-19 Testing
By now, readers are aware that testing in the United States for the novel coronavirus COVID-19 has been embarrassingly slow. Less well known is that…